Ontology highlight
ABSTRACT:
SUBMITTER: Baertsch MA
PROVIDER: S-EPMC7791127 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
Blood cancer journal 20210107 1
Lenalidomide (LEN) maintenance (MT) post autologous stem cell transplantation (ASCT) is standard of care in newly diagnosed multiple myeloma (MM) but has not been compared to other agents in clinical trials. We retrospectively compared bortezomib (BTZ; n = 138) or LEN (n = 183) MT from two subsequent GMMG phase III trials. All patients received three cycles of BTZ-based triplet induction and post-ASCT MT. BTZ MT (1.3 mg/m<sup>2</sup> i.v.) was administered every 2 weeks for 2 years. LEN MT inclu ...[more]